41 related articles for article (PubMed ID: 24314630)
1. Balancing risks and rewards: How hematologists discuss uncertainty in allogeneic hematopoietic cell transplantation outcomes.
Rodenbach RA; Thordardottir T; Brauer M; Hall AC; Ward E; Smith CB; Campbell TC
Patient Educ Couns; 2024 Jun; 123():108177. PubMed ID: 38341898
[TBL] [Abstract][Full Text] [Related]
2. Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS.
Kanakry CG; Tsai HL; Bolaños-Meade J; Smith BD; Gojo I; Kanakry JA; Kasamon YL; Gladstone DE; Matsui W; Borrello I; Huff CA; Swinnen LJ; Powell JD; Pratz KW; DeZern AE; Showel MM; McDevitt MA; Brodsky RA; Levis MJ; Ambinder RF; Fuchs EJ; Rosner GL; Jones RJ; Luznik L
Blood; 2014 Dec; 124(25):3817-27. PubMed ID: 25316679
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic stem cell transplantation in acute lymphoblastic leukemia patients older than 60 years: a survey from the acute leukemia working party of EBMT.
Roth-Guepin G; Canaani J; Ruggeri A; Labopin M; Finke J; Cornelissen JJ; Delage J; Stuhler G; Rovira M; Potter M; Stadler M; Veelken H; Cahn JY; Collin M; Beguin Y; Giebel S; Nagler A; Mohty M
Oncotarget; 2017 Dec; 8(68):112972-112979. PubMed ID: 29348881
[TBL] [Abstract][Full Text] [Related]
4. Pediatric-inspired therapy compared to allografting for Philadelphia chromosome-negative adult ALL in first complete remission.
Seftel MD; Neuberg D; Zhang MJ; Wang HL; Ballen KK; Bergeron J; Couban S; Freytes CO; Hamadani M; Kharfan-Dabaja MA; Lazarus HM; Nishihori T; Paulson K; Saber W; Sallan SE; Soiffer R; Tallman MS; Woolfrey AE; DeAngelo DJ; Weisdorf DJ;
Am J Hematol; 2016 Mar; 91(3):322-9. PubMed ID: 26701142
[TBL] [Abstract][Full Text] [Related]
5. Haploidentical hematopoietic SCT may be superior to conventional consolidation/maintenance chemotherapy as post-remission therapy for high-risk adult ALL.
Sun YQ; Wang J; Jiang Q; Xu LP; Liu DH; Zhang XH; Liu KY; Huang XJ
Bone Marrow Transplant; 2015 Jan; 50(1):20-5. PubMed ID: 25222501
[TBL] [Abstract][Full Text] [Related]
6. [A decision analysis of validity of allogeneic hematopoietic stem cell transplantation from an HLA-matched sibling donor for adult acute lymphoblastic leukemia in first remission].
Kako S
Rinsho Ketsueki; 2010 Jul; 51(7):464-70. PubMed ID: 20693764
[No Abstract] [Full Text] [Related]
7. A decision analysis of allogeneic hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission who have an HLA-matched sibling donor.
Kako S; Morita S; Sakamaki H; Ogawa H; Fukuda T; Takahashi S; Kanamori H; Onizuka M; Iwato K; Suzuki R; Atsuta Y; Kyo T; Sakura T; Jinnai I; Takeuchi J; Miyazaki Y; Miyawaki S; Ohnishi K; Naoe T; Kanda Y
Leukemia; 2011 Feb; 25(2):259-65. PubMed ID: 21072046
[TBL] [Abstract][Full Text] [Related]
8. Intravenous busulfan-cyclophosphamide as a preparative regimen before allogeneic hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia.
Tang W; Wang L; Zhao WL; Chen YB; Shen ZX; Hu J
Biol Blood Marrow Transplant; 2011 Oct; 17(10):1555-61. PubMed ID: 21549217
[TBL] [Abstract][Full Text] [Related]
9. Unrelated donor allogeneic hematopoietic cell transplantation is underused as a curative therapy in eligible patients from the United States.
Yao S; Hahn T; Zhang Y; Haven D; Senneka M; Dunford L; Parsons S; Confer D; McCarthy PL
Biol Blood Marrow Transplant; 2013 Oct; 19(10):1459-64. PubMed ID: 23811537
[TBL] [Abstract][Full Text] [Related]
10. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.
Kiehl MG; Kraut L; Schwerdtfeger R; Hertenstein B; Remberger M; Kroeger N; Stelljes M; Bornhaeuser M; Martin H; Scheid C; Ganser A; Zander AR; Kienast J; Ehninger G; Hoelzer D; Diehl V; Fauser AA; Ringden O
J Clin Oncol; 2004 Jul; 22(14):2816-25. PubMed ID: 15254049
[TBL] [Abstract][Full Text] [Related]
11. The role of hematopoietic cell transplantation in adult ALL: clinical equipoise persists.
Paulson K; Szwajcer D; Raymond CB; Seftel MD
Leuk Res; 2014 Feb; 38(2):176-9. PubMed ID: 24314630
[TBL] [Abstract][Full Text] [Related]
12. Indications for Allogeneic HCT in Adults with Acute Lymphoblastic Leukemia in First Complete Remission.
Arslan S; Pullarkat V; Aldoss I
Curr Treat Options Oncol; 2021 Jun; 22(7):63. PubMed ID: 34097131
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
